Cleveland BioLabs (United States)

Recent papers from Cleveland BioLabs (United States)

1. Abstract 1488: Structure-guided dual targeting of EZH2 and dopamine D1 receptor suppresses TNBC growth and metastasisCancer Research · 2026
2. Norad long noncoding RNA, a decoy for pumilio RNA-binding proteins, elevates fetal hemoglobin levelsBlood · 2025
3. Alpha-thalassemia and red blood cell heterogeneity in sickle cell trait: Interim findings from the achieving understanding of the natural history of sickle cell trait (AUNT) studyBlood · 2025
4. SMALL MOLECULES WHICH CAN KEEP THE ECTODOMAINS OF HUMAN FcγRIIIa “CLOSED”: THERAPY FOR AUTOIMMUNE THROMBOCYTOPENIA PURPURA?2025
5. Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicineProceedings of the National Academy of Sciences · 2024
6. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MSNeurology Neuroimmunology & Neuroinflammation · 2023
7. Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicineProceedings of the National Academy of Sciences · 2023
8. Microfluidic concurrent assessment of red blood cell adhesion and microcapillary occlusion: potential hemorheological biomarkers in sickle cell diseaseSensors & Diagnostics · 2023
9. The small HDL particle hypothesis of Alzheimer's diseaseAlzheimer s & Dementia · 2022
10. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapyOncogene · 2017
11. Asxl2−/− Mice Exhibit De Novo Cardiomyocyte Production during AdulthoodJournal of Developmental Biology · 2016
12. Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity MelanomasCancer Research · 2016
13. Discovery of a Carbazole-Derived Lead Drug for Human African TrypanosomiasisScientific Reports · 2016
14. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastomaNeuro-Oncology · 2016
15. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune ResponsesPLoS ONE · 2016
16. Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical ModelsCancer Research · 2016
17. Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8 ⁺ T-cell axisProceedings of the National Academy of Sciences · 2016
18. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer originCell Cycle · 2015
19. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanismOncotarget · 2015
20. The 2012/2013 ABRF Proteomic Research Group Study: Assessing Longitudinal Intralaboratory Variability in Routine Peptide Liquid Chromatography Tandem Mass Spectrometry Analyses*Molecular & Cellular Proteomics · 2015